> **Annual General Meeting of Galenica Ltd. passes all motions and approves dividend of CHF 2.50 per share - Galenica.com**

> All motions of the Board of Directors were approved with broad consensusThe Annual General Meeting re-elected all members of the Board of DirectorsA dividend of CHF

- Language: en
- Last Modified: 2026-11-20
- Source: <https://www.galenica.com/en/storyhub/eqs/9dba3453-a7f2-409b-b68e-fd7f73455fa2.php>
- Alternate (fr): <https://www.galenica.com/fr/storyhub/eqs/9dba3453-a7f2-409b-b68e-fd7f73455fa2.php>
- Alternate (de): <https://www.galenica.com/de/storyhub/eqs/9dba3453-a7f2-409b-b68e-fd7f73455fa2.php>
- Search: <https://www.galenica.com/en/search/index.php?searchTerm={search_term_string}>

---

Press release  2026/04/21

# Annual General Meeting of Galenica Ltd. passes all motions and approves dividend of CHF 2.50 per share

- All motions of the Board of Directors were approved with broad consensus
- The Annual General Meeting re-elected all members of the Board of Directors
- A dividend of CHF 2.50 per share was approved – an increase of 8.7%
- The Annual General Meeting approved the introduction of a capital range

The ninth Annual General Meeting of Galenica Ltd. was attended by 496 shareholders, representing a total of 75.2% of the registered voting shares of Galenica Ltd. They approved all the motions of the Board of Directors with broad consensus. These included the 2025 annual financial statements of Galenica Ltd., the management report, the report on non-financial matters and the consolidated financial statements of the Galenica Group.

Markus R. Neuhaus, Chairman of the Board of Directors of Galenica, explains: “The clear voting results show that our shareholders support the path we have chosen. They confirm confidence in Galenica’s strategic direction and in our ability to develop Switzerland’s healthcare system in the long term.”

### Dividend of CHF 2.50 per share – increase of 8.7%

Shareholders also approved an increase in the dividend for the 2025 financial year to CHF 2.50 per share, compared with CHF 2.30 in the previous year. This corresponds to an expected distribution of CHF 125.0 million. Galenica continues to pursue a sustainable dividend strategy and aims to keep the dividend for the 2026 financial year at the previous year’s level at least.

### Formal resolutions: Introduction of the capital range approved

The Annual General Meeting approved the actions of the Board of Directors and the Executive Committee for the 2025 financial year. The shareholders also approved the Remuneration Report 2025 in a consultative vote and approved the maximum total remuneration for the Board of Directors and Executive Committee for the 2027 financial year.

The Annual General Meeting also approved the introduction of a capital range. This enables the Board of Directors to flexibly increase or decrease the company’s share capital within a defined range, thus enhancing financial and strategic flexibility.

### Composition of the Board of Directors approved

Dr. Markus R. Neuhaus was approved by the shareholders as a member and Chairman of the Board of Directors for another term of office, having received 98.9% of the votes. The other current members of the Board of Directors were also re-elected for another term of office with very broad consensus.

| All voting results and the minutes of the Annual General Meeting will shortly be published on the Galenica website. |
| --- |

[General Meeting 2026](https://eqs-cockpit.com/c/fncls.ssp?u=1e8460c6797371b0180ad34d199023ac&inline_display=1)

Share post:

[back](https://www.galenica.com/en/storyhub/index.php)

## Media inquiries & contact

Do you have questions about Galenica?
Get in touch with us.

[Media inquiries & contact](https://www.galenica.com/en/medien-news/medienkontakte.php)

## You might also be interested in this

Press releases

2026/11/18

#### Verfora acquires majority stake in distribution partner Qpharma

With Qpharma, Verfora is gaining an established Polish pharmaceutical distributor with a strong distribution platform in Central and Eastern Europe.

[Verfora acquires majority stake in distribution partner Qpharma](https://www.galenica.com/en/storyhub/eqs/86792312-b676-44cf-85a8-3274a5ad078e.php)

Press releases

2026/10/26

#### Galenica successfully places a bond of over CHF 200 million

Today, Galenica successfully placed a fixed rate bond of over CHF 200 million. The bond has a term of 4 years and an annual coupon of 1.2775%.

[Galenica successfully places a bond of over CHF 200 million](https://www.galenica.com/en/storyhub/eqs/216bfdff-51da-47a5-b9fd-a0fb4222acf2.php)

Ad hoc announcements

2026/10/22

#### Galenica continues growth trajectory and confirms outlook for 2026

Galenica increases sales by 5.7% to CHF 3,172.0 million in the first nine months of 2026. The pharmacy business and home care are key contributors to growth.

[Galenica continues growth trajectory and confirms outlook for 2026](https://www.galenica.com/en/storyhub/eqs/75d2d9ff-4b40-4a24-8f9a-71d7d8e85670.php)

2026/09/17

#### Five football pitches full of medication – and one system for emergencies

Millions of packs of medicines are stored in Burgdorf. Some of them are intended for the moment when the market can no longer guarantee supply. How this compulsory stock works and is drawn upon, why it is far from being a dusty emergency reserve, and what role the Galenica network company Alloga plays in supplying Switzerland.

[Five football pitches full of medication – and one system for emergencies](https://www.galenica.com/en/news/entries/20260915-6827872869-news.php)

2026/09/01

#### A new gem joins the network: Galenica acquires Bären Apotheke am Zytglogge

The long-established Bären Apotheke am Zytglogge has been part of Bern’s cityscape for generations. Since 1 September 2026, it has been part of the Galenica network and continues to operate under the name “Bären Vita Zytglogge” with a new concept. This preserves a piece of Bern’s history while opening up new prospects for its future.

[A new gem joins the network: Galenica acquires Bären Apotheke am Zytglogge](https://www.galenica.com/en/news/entries/20260831-1530729059-news.php)

2026/08/31

#### Creating New Spaces in Harmony with Our Culture

The world of work is constantly evolving, and Galenica is evolving with it. As part of our transformation, we are actively shaping the future. This is reflected not only in the way we collaborate, but also in the environments in which we work.

[Creating New Spaces in Harmony with Our Culture](https://www.galenica.com/en/news/entries/20260828-4185621035-news.php)

Ad hoc announcements

2026/08/06

#### Galenica maintains its track record of consistent growth

Galenica increases sales by 7.1% to CHF 2,136.5 million in the first half of 2026. Adjusted<sup>1</sup> EBIT increases by 7.1% to CHF 117.7 million.

[Galenica maintains its track record of consistent growth](https://www.galenica.com/en/storyhub/eqs/56b03300-1d96-40ad-8ba5-2aa0e5bb109b.php)

2026/06/30

#### Change in the Executive Committee of Labor Team

Alain M. Cahen will step down as CEO of Labor Team at the end of June 2026 and will also leave the Executive Committee. COO Thomas Brinkmann will take over on an interim basis.

[Change in the Executive Committee of Labor Team](https://www.galenica.com/en/news/entries/20260630-1601920926-news.php)

Video

2026/06/18

#### Coordinated basic care: From pilot projects to system solutions

Collaboration between different healthcare providers is already being tested in numerous pilot projects. One recent example is the Baselland supply model, which also involves participation from pharmacies in the Galenica network. The task going forward is to develop these approaches systematically and translate them into sustainable, broad-based system solutions. Daniele Madonna, Chief Pharmacies Category Management & Health Services, called for this step at this year’s Healthcare Professionals Initiative on 5 June 2026.

[Coordinated basic care: From pilot projects to system solutions](https://www.galenica.com/en/news/entries/20260617-4349880772-news.php)

Video

2026/06/01

#### Sun Store Renens: First pharmacy in Western Switzerland to introduce the new concept

With the redesigned Sun Store pharmacy in Renens (VD), the first pharmacy in Western Switzerland is opening with a completely new concept. It places a strong focus on personalised advice, healthcare services and the overall customer experience. The aim is to further improve people’s access to low-threshold primary care services.

[Sun Store Renens: First pharmacy in Western Switzerland to introduce the new concept](https://www.galenica.com/en/news/entries/20260428-7147085906-news.php)